{"id":5140,"date":"2024-05-20T05:56:12","date_gmt":"2024-05-20T05:56:12","guid":{"rendered":"https:\/\/www.vistaar.ai\/?post_type=news&#038;p=5140"},"modified":"2024-05-20T05:56:29","modified_gmt":"2024-05-20T05:56:29","slug":"supernus-pharma-selected-vistaar","status":"publish","type":"news","link":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/","title":{"rendered":"Supernus Pharma selected Vistaar"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:70%\">\n<p class=\"wp-block-paragraph\">Supernus Pharmaceuticals, Inc., a leading pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, has recently selected Vistaar, a leading provider of regulatory intelligence solutions. This collaboration aims to enhance Supernus Pharma\u2019s global regulatory, clinical, and compliance capabilities.As a company committed to revolutionizing the healthcare industry, Supernus Pharma recognizes the critical importance of staying up-to-date with the ever-evolving regulatory landscape.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:30%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"200\" src=\"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg\" alt=\"Vistaar\" class=\"wp-image-2670\"\/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">By leveraging Vistaar\u2019s regulatory intelligence solutions, Supernus Pharma aims to ensure compliance with all regulatory requirements across various therapeutic areas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vistaar\u2019s combination of robust technology and experienced global regulatory intelligence team makes it the ideal choice for companies seeking innovative solutions to navigate diversity of the regulatory landscape in BioPharma. The selection of Vistaar by Supernus further reinforces its position as competent provider of regulatory intelligence solutions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Both Supernus Pharma and Vistaar are confident that this partnership will drive significant advancements in the pharmaceutical industry and foster innovation in drug development and regulatory compliance.<\/p>\n","protected":false},"featured_media":0,"template":"","news_categories":[],"class_list":["post-5140","news","type-news","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Supernus Pharma selected Vistaar - Vistaar<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Supernus Pharma selected Vistaar - Vistaar\" \/>\r\n<meta property=\"og:description\" content=\"Supernus Pharmaceuticals, Inc., a leading pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, has recently selected Vistaar, a leading provider of regulatory intelligence solutions. This collaboration aims to enhance Supernus Pharma\u2019s global regulatory, clinical, and compliance capabilities.As a company committed to revolutionizing the healthcare industry, Supernus Pharma [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/\" \/>\r\n<meta property=\"og:site_name\" content=\"Vistaar\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-05-20T05:56:29+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/\",\"url\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/\",\"name\":\"Supernus Pharma selected Vistaar - Vistaar\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vistaar.ai\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Vistaar.jpg\",\"datePublished\":\"2024-05-20T05:56:12+00:00\",\"dateModified\":\"2024-05-20T05:56:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vistaar.ai\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Vistaar.jpg\",\"contentUrl\":\"https:\\\/\\\/www.vistaar.ai\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Vistaar.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/supernus-pharma-selected-vistaar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Supernus Pharma selected Vistaar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/#website\",\"url\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/\",\"name\":\"Vistaar\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stage-websites.ddismart.com\\\/vistaar\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supernus Pharma selected Vistaar - Vistaar","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/","og_locale":"en_US","og_type":"article","og_title":"Supernus Pharma selected Vistaar - Vistaar","og_description":"Supernus Pharmaceuticals, Inc., a leading pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, has recently selected Vistaar, a leading provider of regulatory intelligence solutions. This collaboration aims to enhance Supernus Pharma\u2019s global regulatory, clinical, and compliance capabilities.As a company committed to revolutionizing the healthcare industry, Supernus Pharma [&hellip;]","og_url":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/","og_site_name":"Vistaar","article_modified_time":"2024-05-20T05:56:29+00:00","og_image":[{"url":"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/","url":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/","name":"Supernus Pharma selected Vistaar - Vistaar","isPartOf":{"@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/#primaryimage"},"image":{"@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg","datePublished":"2024-05-20T05:56:12+00:00","dateModified":"2024-05-20T05:56:29+00:00","breadcrumb":{"@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/#primaryimage","url":"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg","contentUrl":"https:\/\/www.vistaar.ai\/wp-content\/uploads\/2024\/01\/Vistaar.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/supernus-pharma-selected-vistaar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stage-websites.ddismart.com\/vistaar\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/stage-websites.ddismart.com\/vistaar\/news\/"},{"@type":"ListItem","position":3,"name":"Supernus Pharma selected Vistaar"}]},{"@type":"WebSite","@id":"https:\/\/stage-websites.ddismart.com\/vistaar\/#website","url":"https:\/\/stage-websites.ddismart.com\/vistaar\/","name":"Vistaar","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stage-websites.ddismart.com\/vistaar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/stage-websites.ddismart.com\/vistaar\/wp-json\/wp\/v2\/news\/5140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage-websites.ddismart.com\/vistaar\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/stage-websites.ddismart.com\/vistaar\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/stage-websites.ddismart.com\/vistaar\/wp-json\/wp\/v2\/media?parent=5140"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/stage-websites.ddismart.com\/vistaar\/wp-json\/wp\/v2\/news_categories?post=5140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}